바로가기메뉴

본문 바로가기 주메뉴 바로가기

Isolated Volume Response to a Bronchodilator and GOLD Classification in Patients with COPD

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2005, v.59 no.1, pp.3-29















  • Downloaded
  • Viewed

Abstract

Background : Chronic obstructive lung disease is characterized by smoke-related, gradually progressive, fixed airflow obstructions. However, some studies suggested that a reversible bronchial obstruction is common in chronic obstructive lung disease. Such reversibility persists despite the continued treatment with aerosolized bronchodilators and it appears to be related to the diminution in symptoms. The isolated volume response to a bronchodilator is defined as a remarkable increase in the FVC in response to the administration of a bronchodilator whereas the FEV1 remains unchanged. This has been suggested in patients with severe emphysema. Therefore, the aim of this study was to determine the relationship between the response to a bronchodilator and the severity of an airflow obstruction in COPD patients using the GOLD classification. Methods : This study examined 124 patients with an airway obstruction. The patients underwent spirometry, and the severity of the airflow obstruction was classified by GOLD. The response groups were categorized by an improvement in the FVC or FEV1 > 12%, and each group was analyzed. Results : Most subjects were men with a mean age of 65.9±8.5 years. The mean smoking history was 41.26±20.1 pack years. The isolated volume response group had relatively low FEV1 and FVC values compared with the other groups. (p<0.001) Conclusion : In this study, an isolated volume response to a bronchodilator is a characteristic of a severe airway obstruction, which is observed in patient with a relatively poorer baseline lung function. (Tuberc Respir Dis 2005; 59: 23-29)

keywords
COPD, Bronchodilator, GOLD, Isolated volume response, COPD, Bronchodilator, GOLD, Isolated volume response

Reference

1.

(1974) Bronchial component in chronic obstructive lung disease,

2.

(2005) The bronchodilator response to salmeterol is maintained with regular,long-term use in patients with COPD,

3.

(2004) Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease,

4.

(1979) Determination of bronchodilation in the clinical pulmonary function laboratory:role of changes in static lung volumes,

5.

(chest1983) Should the FVC be considered in evaluating response to bronchodilator,

6.

(2000) Mechanisms for isolated volume response to a bronchodilator in patients with COPD,

7.

(2002) Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation,

8.

(2004) Change of lung volumes in chronic obstructive pulmonary disease patients with improvement of airflow limitation after treatment,

9.

(1991) Lung function testing:selection of reference values and interpretative strategies,

10.

(2001) Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease,

11.

(1983) Bronchodilator testing:confidence intervals derived from placebo inhalations,

12.

(2004) Physiologic similarities and differences between COPD and asthma,

13.

(1998) Measurement of symptoms,lung hyperinflation,and endurance during exercise in chronic obstructive pulmonary disease,

14.

(1999) Does inhaled albuterol improve diaphragmatic contractility in patients with chronic obstructive pulmonary disease,

15.

(2001) Use of forced inspiratory vital capacity to identify bronchodilator reversibility in obstructive lung disease,

16.

(2001) Evaluation of bronchodilator responses in patients with "irreversible" emphysema. ,

17.

(1992) The utility of spirometry in the diagnosis of reversible airways obstruction,

18.

(eurrespirjsuppl1993) report Working Party Standardization of Lung Function Tests European Community for Steel and Coal,

19.

(1996) Membranous bronchioles and connective tissue network of normal and emphysematous lungs,

20.

(2004) Assessment of emphysema in COPD:a functional and radiologic study,

21.

(1983) Patterns of response to inhaled bronchodilators in asthmatics,

Tuberculosis & Respiratory Diseases